Cost-Effectiveness Analysis of Drugs Used in Intensive Care Units of Hospitals

Khanbabayi Gol, Sajad; Khanbabayi Gol, Mehdi

doi:https://doi.org/10.5281/zenodo.14735812

Cost-Effectiveness Analysis of Drugs Used in Intensive Care Units of Hospitals

Document Type : Original Article

Authors

Sajad khanbabayi gol ¹

Mehdi khanbabayi gol ²

¹ Accountant, Shahindezh Islamic Azad University, Shahindezh, Iran

² Anesthesiologist, Tabriz University of Medical Sciences, Tabriz, Iran.

https://doi.org/https://doi.org/10.5281/zenodo.14735812

Abstract

This study conducts a cost-effectiveness analysis (CEA) of pharmaceuticals utilized in intensive care units (ICUs) across hospitals. The objective is to assess the economic viability of commonly prescribed drugs in critical care settings, considering both their therapeutic efficacy and financial implications. Data were gathered from ICU patients, including drug consumption, treatment outcomes, and associated costs. The analysis involved calculating the incremental cost-effectiveness ratio (ICER) for each drug, comparing it with standard treatment protocols. Results indicate a significant variance in cost-effectiveness among the drugs, with certain therapies providing optimal clinical outcomes at lower costs. The findings suggest that strategic drug selection based on cost-effectiveness could optimize resource allocation in ICUs, improving patient outcomes while minimizing expenditures. This research highlights the importance of integrating economic evaluation into clinical decision-making in critical care environments.

Keywords

Cost-effectiveness

ICU

Incremental cost-effectiveness ratio

Critical care

Subjects